Article info
PDFOriginal research
Development of a list with renally relevant drugs as a tool to increase medicines optimisation in patients with chronic kidney disease
- Correspondence to Alexander Schütze, Department of Pharmacy, Klinikum Fulda gAG, Fulda 36043, Germany; alex12884{at}t-online.de
Citation
Development of a list with renally relevant drugs as a tool to increase medicines optimisation in patients with chronic kidney disease
Publication history
- Received October 21, 2020
- Revised April 12, 2021
- Accepted April 27, 2021
- First published May 13, 2021.
Online issue publication
October 18, 2023
Article Versions
- Previous version (19 December 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2023. No commercial re-use. See rights and permissions. Published by BMJ.